Source: International Congress 2019 – Biology of lung cancer
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
J. Vengoechea (Zaragoza, Spain), M. Ponce-Alonso (Madrid, Spain), A. Figueredo (Zaragoza, Spain), E. Micholé (Zaragoza, Spain), L. Torralba (Zaragoza, Spain), J. Errasti (Zaragoza, Spain), E. Vera (Zaragoza, Spain), A. Rezusta (Zaragoza, Spain), R. Del Campo (Madrid, Spain), S. Bello (Zaragoza, Spain). Changes in the pulmonary microbiome associated with lung cancer. 3663

Member's Comments

No comment yet.

Related content which might interest you: Bacterial colonisation in the lower airways of patients with lung cancer Source: Eur Respir J 2007; 30: Suppl. 51, 403s Year: 2007 The microbiome in interstitial lung disease Source: Lung Science Conference 2015 Year: 2015 Pulmonary function testing in patients with lung cancer Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology Year: 2012 The association of lung cancer with pulmonary fibrosis Source: ERJ Open Res, 8 (1) 00505-2021; 10.1183/23120541.00505-2021 Year: 2022 Lung function predicts lung cancer Source: Eur Respir J 2010; 35: 1421-1422 Year: 2010 The pulmonary microbiome in sarcoidosis is similar to other parenchymal lung diseases Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018 Lung cancer and interstitial lung disease Source: International Congress 2018 – State of the art session: Thoracic oncology Year: 2018 Polymorphisms associated with lung cancer are closely related to COPD Source: Eur Respir J 2007; 30: Suppl. 51, 136s Year: 2007 Factors associated with regional occurance of lung cancer Source: Annual Congress 2010 - Epidemiology of lung cancer Year: 2010 Does the lung function affect the survival time in patients with resected non-small cell lung cancer? Source: Annual Congress 2007 - Lung function parameters before and after thoracic surgery Year: 2007 Relationship between pulmonary function and lung cancer surgery outcome Source: Eur Respir J 2004; 24: Suppl. 48, 478s Year: 2004 Prevalence and characterization of interstitial lung disease in a lung cancer screening program Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009 The Asian experience in co-existing lung cancer and interstitial lung disease Source: International Congress 2018 – Imminent global problems in lung cancer require joint action: time for an international alliance! Year: 2018 Pivotal role of the HMGB1/sRAGE axis in drug-induced lung injury in advanced lung cancer with pre-existing interstitial lung disease Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Outcome of treated advanced non-small cell lung cancer associated with central airway obstruction Source: Eur Respir J 2006; 28: Suppl. 50, 796s Year: 2006 Influence of the lung resection to small airways function in patients with limited and normal lung function and primary non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 718s Year: 2006 Lung cancer and associated diseases Source: Eur Respir J 2001; 18: Suppl. 33, 66s Year: 2001